Modifications of andrographolide to increase some biological activities: A patent review (2006-2011)

Expert Opinion on Therapeutic Patents

Volumn 22, Issue 2, 2012, Pages 169-180

  Aromdee, Chantana ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Analgesic; Andrographolide; Anti inflammatory; Antibacterials; Anticancer; Antidiabetic; Antipyretic; Antivirals

Indexed keywords

11,12 DIDEHYDRO 14 DEOXYANDROGRAPHOLIDE; 14 ACETYL 3,19 ISOPROPYLIDENYLANDROGRAPHOLIDE; 14 ACETYLANDROGRAPHOLIDE; 14 DEOXYANDROGRAPHOLIDE; 3,19 DIPALMITOYL 14 DEOXY 11,12 DIDEHYDROANDROGRAPHOLIDE; 3,19 ISOPROPYLIDINYLANDROGARPHOLIDE; ALPHA GLUCOSIDASE; ANDROGRAPHOLIDE; ISOANDROGRAPHOLIDE; NEOANDROGRAPHOLIDE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPYRETIC ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; DRUG STRUCTURE; ENZYME INHIBITION; EPOXIDATION; HUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); REVIEW;

ANALGESICS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIPYRETICS; DITERPENES; DRUG DESIGN; HUMANS; HYPOGLYCEMIC AGENTS; LEGISLATION, DRUG; MOLECULAR STRUCTURE; PATENTS AS TOPIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84857577927     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2012.661718     Document Type: Review

References (93)

1. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. Council for Scientific and Industrial Research; New Delhi: 1956
2. Chang HM, But PPH. Pharmacology and Applications of Chinese Materia Medica. World Scientific Publishing Co. Singapore: 1989
3. Madav S, Tripathi C, Tandan SK, Mishra S. Analgesic, antipyretic, and antiulcerogenic effects of andrographolide. Ind J Pharm Sci 1995;57:121-5
4. Suebsasana S, Pongnaratorn P, Sattayasai J, et al. Analgesic, antipyretic, anti-inflammatory and toxic effects of andrographolide derivatives in experimental animals. Arch Pharm Res 2009;32:1191-200
5. Abu-Ghefreh AA, Canatan H, Ezeamuzie CI. In vitro and in vivo anti-inflammatory effects of andrographolide. Int Immunol 2009;9:313-18
6. Sheeja K, Guruvayoorappan C, Kuttan G. Antiangiogenic activity of Andrographis paniculata extract and andrographolide. Int Immunol 2007;7:211-21
7. Shen Y-C, Chen C-F, Chiou W-F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol 2002;135:399-406
8. Aromdee C, Seubsasana S, Sriubolmas N, et al. Effect of the derivatives of Andrographolide on the morphology of B. subtilis. Arch Pharm Res 2011;34:71-7
9. Wang Z, Yu P, Xu L, et al. Design, synthesis and antibacterial activity of novel andrographolide derivatives. Bioorg Med Chem 2010;18:2469-74.qourum sensing
10. Fan AL, Li XM, Gao JM, et al. Preparation of acetylandrographolide and comparison of its antimicrobial activity and allopathic effect. Acta Bot Boreal-Occid Sin 2006;26:1905
11. Shen YH, Li RT, Xiao WL, et al. ent-Labdane diterpenoids from Andrographis paniculata. J Nat Prod 2006;69:319-22
12. Ko H-C, Wei B-L, Chiou W-F. The effect of medicinal plants used in Chinese folk medicine on RANTES secretion by virus-infected human epithelial cells. J Ethnopharmacol 2006;107:205-10
13. Vajpayee M, Malhotra N. Antiviral drugs against herpes infections. Ind J Pharmacol 2000;32:330-8
14. Wiart C, Kumar K, Yusof MY, et al. Antiviral properties of ent-labdene diterpenes of Andrographis paniculata Nees, inhibitors of herpes simplex virus type 1. Phytother Res 2005;19:1069-70
15. Aromdee C, Seubsasana S, Ekalaksananan T, et al. Stage of action of naturally. occurring andrographolides and their semi-synthetic analogues against herpes simplex virus type 1 in vitro. Planta Med 2011;77:915-21
16. Seubsasana S, Pientong C, Ekalaksananan T, et al. A Potential Andrographolide analogue against the replication of herpes simplex virus type-1 in vero cells. Med Chem 2011;7:237-44
17. Nanduri S, Nyavanandi VK, Thunuguntla SS, et al. Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents. Bioorg Med Chem Lett 2004;14:4711-17
18. Kumar RA, Sridevi K, Kumar NV, et al. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 2004;92:291-5
19. Jada SR, Subur GS, Matthews C, et al. Semisynthesis and in vitro anticancer activities of andrographolide analogues. Phytochemistry 2007;68:904-12
20. Puri A, Saxena R, Saxena RP, Saxena KC. Immunostimulant agents from Andrographis paniculata. J Nat Prod 1993;56:995-9
21. Yu BC, Hung CR, Chen WC, Cheng JT. Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats. Planta Med 2003;69:1075-9
22. Xu HW, Dai GF, Lui GZ, et al. Synthesis of andrographolide derivatives: a new family of a-glucosidae inhibitors. Biorg Med Chem 2007;15:4247-55
23. Zhang Z, Jiang J, Yu P, et al. Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment. J Transitional Med 2009;7:62
24. Dai GF, Xu HW, Wang JF, et al. Studies of the novel a-glucosidase inhibitory activity and structure-activity relationships for andrographolide analogues. Bioorg Med Chem Lett 2006;16:2710-13
25. Xu HW, Lui GZ, Dai GF, et al. Modification of 15-alkylidene andrographolide derivatives as alpha-glucosidase inhibitor Drug Discov Ther. 2007;1:73-7
26. Univ Jinan. Andrographolide derivatives useful in the treatment of cancer, inflammation, diabetes and bacterial infection and their preparation. CN 101817805; 2010
27. Liang FP, Lin CH, Kuo CD, et al. Suppressionof v-Src Transformation via degradation of the v-Src Protein and attenuation of the Erk signaling pathway. J Biol Chem 2008;283:5023-33
28. Fujita T, Fujitani R, Takeda Y, et al. 1984. On the diterpenoids of andrographis paniculata: X-ray crystallographic analysis of andrographolide and structure determination of new minor diterpenoids. Chem Pharm Bull 1984;32:2117-25
29. Rao YK, Vimalamma G, Rao CV, Tzeng Y-M. Flavonoids and andrographolides from Andrographis paniculata. Phytochemistry 2004;65:2317-21
30. Jada SR, McLillan K, Hamzah A, et al. 14-Acetylandrographolide J Chem Crystallogr. 2006;36:93-7
31. Sambyal VS, Goswami KN. Refined crystal and molecular structure of andrographolide-diterpene. Cryst Res Tech 1995;30:629-36
32. Xu HW, Fu DG, Lui GZ, et al. Synthesis of andrographolide derivatives: a new family of alpha-glucosidase inhibitors. Bioorg Med Chem 2007;15:4247-55
33. Teh JBJ, Sagineedu RS, Fun HK, et al. 14-deoxy-11,12-didehydro-3,19- isopropylidenylandrographolide. Acta Cryst Sect E Struct Reports Online 2006;published online 13 January 2006; doi:10.1107/S1600536806000699
34. Sattayasai J, Srisuwan S, Arkaravichien T, Aromdee C. Effect of andrographolide on sexual function, vascular reactivity and serum testosterone level in rodents. Food Chem Toxicol 2010;48:1934-8
35. Hunan Lushan Natural Pharmaceutical Co. Method for producing high-purity dehydrated andrographolide. CN1962650; 2007
36. Guan HP, Kong LR, Cheng C, et al. Protective Role of 14-Deoxy-11, 12-didehydroandrographolide, a Noncytotoxic Analogue of Andrographolide, in Allergic Airway Inflammation J Nat Prod. 2011;74:1484-90
37. Chao WW, Lin BF. Isolation and Identification of Bioactive compounds in Andrographis paniculata (Chuanxinlian). Chin Med 2010;5:17-Available from: http://www. cmjournal.org/content/5/1/17
38. Lim CW, Chan TK, Ng DSW, et al. Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer. Clin Exp Pharmacol Physiol 2011;"Accepted Article"; doi:10.1111/ j.1440-1681.2011.05633.x
39. Varma A, Padh H, Shrivastava N. Andrograoholide: a new plant-derived antineoplastic entity on horizon. Hindawi Publishing Corp.; Egypt: 2011. p. 1-9
40. Panossian A, Hovhannisyan A, Mamikonyan G, et al. Pharmacokinetic and oral bioavalability of andrographolide from andrographis paniculata fixed combination Kan Jang in rats and humans. Phytomedicine 2000;7:351-64
41. He X, Li J, Gao H, et al. Four new andrographolide metabolites in rats. Tetrahedron 2003;59:6603-7
42. He X, Li J, Gao H, Qui F. Six new andrographolide metabolite in rats. Chem Pharm Bull 2003;51:586-9
43. Cui L, Qui F, Yao X. Isolation and identification of seven glucuronide conjugates of andrographolide human urine. Drug Metab Dispos 2005;25:285-93
44. Cui L, Qui F, Wang NL, et al. A new glucuronide metabolite of andrographolide in human. Chin Chem Lett 2005;16:369-71.Available from: http:// www.imm.ac.cn/journal/cc1.html
45. Aromdee C, Fawcett JP, Ferguson MM, Ledger R. Serum pilocarpine esterase activity and response to oral pilocarpine. Biochem Mol Med 1996;59:57-61
46. Zhejiang Jiuxu Pharmaceutical Co. Method for preparation of andrographolide sodium bisulfite intermediate. CN10122001; 2008
47. Huang Jinxiu. Method for preparation of potassium sodium dehydroandrographolide succinate (Yanhuning) and its medicinal composite. CN1927854; 2007
48. Zhengzhou Univ. Preparation of 14-deoxy-11,12-dehydroandrographolide C-glycoside derivatives. CN100999535; 2007
49. Chen ZG, Zhu Q, Zong MH, et al. Enzymatic synthesis and antibacterial activity of andrographolide derivatives Process. Biochemistry 2011;46:1649-53
50. Jiang X, Yu P, Jiang J, et al. Synthesis and evaluation of antibacterial activities of andrographolide analogues. Eur J Med Chem 2009;44:2936-43
51. Jinan Univ. Preparation of synergic composition containing andrographolide or derivative and pharmaceutically-acceptable salt thereof and thioctic acid or dihydrothioctic acid with antibacterial, antiviral, anti-inflammatory, antitumor and antidiabetic effects. CN101590037; 2009
52. Calbrese C, Berman SH, Babish JG, et al. A phase 1 trial of andrographolide in HIV positive patients and normal volunteers Phytother Res. 2000;14:333-8
53. Chang RH, Ding L, Chen G-Q et al. Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus. Proc Soc Exp Biol Med 1991;197:59-66
54. Wang B, Ge L, Huang WL, et al. Synthesis and preliminary anti-HIV activities of andrographolide derivatives. Med Chem 2010;6:252-8
55. Wang B, Li J, Huang WL, et al. Synthesis and biological evaluation of andrographolide derivatives as potent anti-HIV agents. Chin Chem Lett 2011;22:781-4
56. King Spalding LLP. Andrographolide derivatives to treat viral infections. US20060333785; 2006
57. Roizman B, Knipe DM, Whitley RJ. The replication of Herpes simplex viruses. In: Knipe DM, HowleyFields' PM, editors. Virology. 5th edition. Lippincott-Williams and Wilkins; New York: 2007
58. Liang Y, Sharon A, Grier J, et al. 5¢-O-Aliphatic and amino acid ester prodrugs of (-)-b-D-(2R,4R)-dioxolanethymine (DOT): Synthesis, anti-HIV activity, cytotoxicity and stability studies. Bioorg Med Chem 2009;17:1404-9
59. Yoshikawa M, Sakuraba M, Kusashio K. Study of the phosphorylation of nucleosides with phosphorus trihalide. Bull Chem Soc Jpn 1970;43:456-61
60. Chen JX, Xue HJ, Ye WC, et al. Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro. Biol Pharm Bull 2009;32:1385-91
61. Beijing Inst Med & Indus Biotech. Andrographolide trimaleate mono-K salt and tri-K salt and their medical composition. CN100408571; 2008
62. Deng WL, Nie RJ, Lui JY. Comparison of pharmacological effect of four andrographolides. Yaoxue Tongbao 1982;17:195-8
63. Hildalgo MA, Romero A, Figueroa J, et al. Andrographolide interferes with binding of nuclear factor-kB to DNA in HL-60-derived neutrophilic cells. Br J Pharmacol 2005;144:680-6
64. Li J, Huang W, Zhang H, et al. Synthesis of andrographolide derivatives and their TNF-alpha and IL-6 expression inhibitory activities. Bioorg Med Chem 2007;17:6891-4
65. China Pharm Univ. Substituted andrographolide derivative, preparing method and pharmaceutical compound thereof. CN1010122112007; 2007
66. Jung M, Park M, Lee HC, et al. Antidiabetic agents from medicinal plants Curr Med Chem. 2006;13:1203-18
67. Faust A, Burkart V, Ulrich H, et al. Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice. Int J Immunopharmacol 1994;16:61-6
68. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acis. Free Radic Biol Med 1997;22:359-78
69. Beijing Yigong Biotechnology Institute. Preparation for dehydroandrographolide and pharmaceutical composition thereof. CN1810794; 2006
70. Changchun Mailing Bioengineering Co. Process for preparing potassium sodium 14-deoxy-11,12-didehydroan drographolide succinate from potassium dehydroandrographolide succinate. CN101260097; 2008
71. Jinan University, Peop. Rep. China, Preparation of andrographolide derivatives and pharmaceutical applications thereof. CN101125850; 2008
72. Beijing Meibeita Pharmaceutical Research Co. Water soluble andrographolide and Dehydroandrographolide amino acid ester derivatives. CN101376651; 2009
73. Zhengzhou Univ. Medical application of 15-benzylidene-14-deoxy- 11,12-dehydroandrographolide derivative in preparing antitumor agents. CN101972247; 2011
74. Shandong Target Drug Research Co. Method for preparing isoandrographolide sulfonate used in pharmaceutical composition. CN101560198; 2009
75. China Pharm Univ. Method for preparation of substituted isoandrographolide derivatives for inhibitive effects on the expression of COX-2, TNF-alpha, and IL-6. CN101029046; 2007
76. Zhengzhou Univ. Method for preparation of isoandrographolide analogs. CN100999520; 2007
77. Zhengzhou Univ. Method for preparation of andrographolide derivates substituted at C-15 position. CN1978437; 2007
78. Zhengzhou Univ. Application of 15-methylene substituted andrographolide derivative in preparing anti-inflammatory, antipyretic and analgesic drugs. CN101416959; 2009
79. Shandong Target Drug Research Co. Preparation of andrographolide derivatives as antiinflammatory, antibacterial, antiviral, and antitumor agents. CN101550161; 2009
80. Dongguan Chang'an Dongyangguang New Drug Research and Development Co., Zhang, Zhongneng. Andrographolide compounds, their preparation method and medical application as antipyretic, anti-inflammatory, antiviral or antibacterial agents. CN102250142; 2011
81. East China Univ Science and Technology, Wuxi Jimin Kexin Shanhe Pharmaceutical Co. Diterpene lactone compound and its application as antibacterial, antiviral agents. CN102199186; 2011
82. Advanced Gene Technology Corp., Taiwan andrographolide and its derivatives as TNF-alpha antagonists. US20060106098; 2006
83. Shandong Target Drug Research Co. Medical application of 3,14,19-triacetyl andrographolide in preparing inflammatory cytokine inhibitor. CN101371832; 2009
84. National University of Singapore. Use of andrographolide compounds for treating inflammation and airway disorders. WO2010110748 2010
85. Hutchison Medipharma Ltd. Naphthane compound, derivative of andrographolide and its medicinal application (for autoimmune disease, tumor, and arteriosclerosis). CN101200465; 2008
86. Hutchison Medipharma Ltd. Preparation of decahydronaphthalene compounds for treating autoimmune disease, cancer, and atherosclerosis. US20080139622; 2008
87. Nanjing Univ of Technology, China Pharm Unive. Substituted andrographolide derivatives as antitumor agents and their preparation, pharmaceutical compositions and use in the treatment of cancer. CN101570524; 2009
88. Dr. Reddy's Research Foundation. Process for the preparation of novel compounds having antitumor activity. IN2000MA00437; 2010
89. Zhengzhou Univ. Method for preparation of andrographolide C15-hydroxymethyl derivatives inhibit alpha-glycosidase and high immunoregulating activity. CN101003527; 2007
90. KBP Biomedical Co. China Novel compounds with antiviral activity and their application. CN101190883; 2008
91. Peop. Rep. China, Synthesis and application of andrographolide derivative as new antiviral agent. CN101190912; 2008
92. Zhengzhou Univ. Application of 15-methylene substituted andrographolide derivative to prepare the medical preparations for preventing and treating hepatitis b. CN101416958; 2009
93. China Pharm Univ Medical application of andrographolide derivatives for treating HIV infection. CN101829110; 2010